These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10448731)

  • 1. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.
    Blackwell JL; Miller CR; Douglas JT; Li H; Reynolds PN; Carroll WR; Peters GE; Strong TV; Curiel DT
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):856-63. PubMed ID: 10448731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.
    Harvey TJ; Burdon D; Steele L; Ingram N; Hall GD; Selby PJ; Vile RG; Cooper PA; Shnyder SD; Chester JD
    Gene Ther; 2010 Aug; 17(8):1000-10. PubMed ID: 20410926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D; Duan L; Freimuth P; O'Malley BW
    Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus calcium phosphate coprecipitates enhance squamous cell carcinoma gene transfer.
    Yi SM; Lee JH; Graham S; Zabner J; Welsh MJ
    Laryngoscope; 2001 Jul; 111(7):1290-6. PubMed ID: 11568557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
    Kasono K; Blackwell JL; Douglas JT; Dmitriev I; Strong TV; Reynolds P; Kropf DA; Carroll WR; Peters GE; Bucy RP; Curiel DT; Krasnykh V
    Clin Cancer Res; 1999 Sep; 5(9):2571-9. PubMed ID: 10499635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients.
    Jee YS; Lee SG; Lee JC; Kim MJ; Lee JJ; Kim DY; Park SW; Sung MW; Heo DS
    Anticancer Res; 2002; 22(5):2629-34. PubMed ID: 12529974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.
    Dmitriev I; Kashentseva E; Rogers BE; Krasnykh V; Curiel DT
    J Virol; 2000 Aug; 74(15):6875-84. PubMed ID: 10888627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
    Lalonde ES; Beyer G; Friedlander PL; Kolls JK
    Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
    He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
    J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
    Toivonen R; Suominen E; Grenman R; Savontaus M
    Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
    van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
    J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
    Morrison J; Briggs SS; Green NK; Thoma C; Fisher KD; Kehoe S; Seymour LW
    Hum Gene Ther; 2009 Mar; 20(3):239-51. PubMed ID: 19257852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.
    van der Poel HG; Molenaar B; van Beusechem VW; Haisma HJ; Rodriguez R; Curiel DT; Gerritsen WR
    J Urol; 2002 Jul; 168(1):266-72. PubMed ID: 12050554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor.
    Wienen F; Nilson R; Allmendinger E; Graumann D; Fiedler E; Bosse-Doenecke E; Kochanek S; Krutzke L
    Biomater Adv; 2023 Jan; 144():213208. PubMed ID: 36442453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
    Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
    Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.
    Hemminki A; Dmitriev I; Liu B; Desmond RA; Alemany R; Curiel DT
    Cancer Res; 2001 Sep; 61(17):6377-81. PubMed ID: 11522629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
    Stanton P; Richards S; Reeves J; Nikolic M; Edington K; Clark L; Robertson G; Souter D; Mitchell R; Hendler FJ
    Br J Cancer; 1994 Sep; 70(3):427-33. PubMed ID: 8080726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.